Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Kinases control of regulated cell death revealing druggable targets for Parkinson’s disease
Heba M. Mansour, Ahmed F. Mohamed, Aiman S. El‐Khatib, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101841-101841
Closed Access | Times Cited: 21

Showing 21 citing articles:

Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance
Xudong Zhu, Shenglong Li
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 44
DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease
Zhong‐Xuan Wang, Yaolin Li, Jiali Pu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6313-6313
Open Access | Times Cited: 22
Lapatinib ditosylate rescues motor deficits in rotenone-intoxicated rats: Potential repurposing of anti-cancer drug as a disease-modifying agent in Parkinson's disease
Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab, et al.
European Journal of Pharmacology (2023) Vol. 954, pp. 175875-175875
Closed Access | Times Cited: 14
Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides
Heba M. Mansour, Aiman S. El‐Khatib
European Journal of Pharmacology (2025), pp. 177529-177529
Closed Access
Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein
Heba M. Mansour, Aiman S. El‐Khatib
Ageing Research Reviews (2023) Vol. 92, pp. 102114-102114
Closed Access | Times Cited: 11
Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs
Dia Advani, Pravir Kumar
Molecular Neurobiology (2024)
Closed Access | Times Cited: 4
The interplay between α-synuclein aggregation and necroptosis in Parkinson’s disease: a spatiotemporal perspective
Huanhuan Xiang
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Identification of necroptosis-related genes in Parkinson’s disease by integrated bioinformatics analysis and experimental validation
Lei Cheng, Zhong-Yan Zhou, Wenting Shi, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms
Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab, et al.
Food and Chemical Toxicology (2023) Vol. 181, pp. 114069-114069
Closed Access | Times Cited: 9
Role of death-associated protein kinase 1 (DAPK1) in retinal degenerative diseases: an in-silico approach towards therapeutic intervention
Arman Firoz, Priti Talwar
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 11, pp. 5686-5698
Closed Access | Times Cited: 7
The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic
Heba M. Mansour
Ageing Research Reviews (2024) Vol. 94, pp. 102195-102195
Closed Access | Times Cited: 2
COVID-19 related neurological manifestations in Parkinson’s disease: has ferroptosis been a suspect?
Fengju Jia, Jing Han
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Repositioning of receptor tyrosine kinase inhibitors
Heba M. Mansour, Aiman S. El‐Khatib
Elsevier eBooks (2023), pp. 353-401
Closed Access | Times Cited: 5
Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature
Maria Regoni, Flavia Valtorta, Jenny Sassone
European Journal of Neuroscience (2023) Vol. 59, Iss. 6, pp. 1079-1098
Open Access | Times Cited: 5
Heat Shock Protein 90 in Parkinson’s Disease: Profile of a Serial Killer
Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab, et al.
Neuroscience (2023) Vol. 537, pp. 32-46
Closed Access | Times Cited: 4
Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor
Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab, et al.
Brain Research (2024) Vol. 1834, pp. 148893-148893
Closed Access | Times Cited: 1
Evaluating the protective role of trimetazidine versus nano-trimetazidine in amelioration of bilateral renal ischemia/reperfusion induced neuro-degeneration: Implications of ERK1/2, JNK and Galectin-3 /NF-κB/TNF-α/HMGB-1 signaling
Fatma E. Hassan, Basma Emad Aboulhoda, Isra H. Ali, et al.
Tissue and Cell (2023) Vol. 85, pp. 102241-102241
Closed Access | Times Cited: 3
Selective Covalent Inhibiting JNK3 by Small Molecules for Parkinson's Diseases
Liang Ouyang, Shuai Wen, Panpan Yang, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 50
Closed Access
From Ideation to Innovation: Integrating Pharmaceutical Innovation and Sustainable Development
Heba M. Mansour, Aiman S. El‐Khatib
World sustainability series (2024), pp. 239-280
Closed Access
Therapeutic Strategies for Combating Reactive Oxygen Species in Cardiovascular Diseases
Heba M. Mansour
Oxidative stress in applied basic research and clinical practice (2024), pp. 25-95
Closed Access
Selective Covalent Inhibiting JNK3 by Small Molecules for Parkinson's Diseases
Liang Ouyang, Shuai Wen, Panpan Yang, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 50
Closed Access
Page 1

Scroll to top